Your browser doesn't support javascript.
loading
Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer.
Klauck, Peter J; Bagby, Stacey M; Capasso, Anna; Bradshaw-Pierce, Erica L; Selby, Heather M; Spreafico, Anna; Tentler, John J; Tan, Aik Choon; Kim, Jihye; Arcaroli, John J; Purkey, Alicia; Messersmith, Wells A; Kuida, Keisuke; Eckhardt, S Gail; Pitts, Todd M.
Afiliación
  • Klauck PJ; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Bagby SM; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Capasso A; University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Bradshaw-Pierce EL; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Selby HM; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Spreafico A; University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Tentler JJ; Takeda California, San Diego, CA, USA.
  • Tan AC; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Kim J; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Arcaroli JJ; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Purkey A; University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Messersmith WA; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Kuida K; University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Eckhardt SG; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Pitts TM; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
BMC Cancer ; 18(1): 136, 2018 02 05.
Article en En | MEDLINE | ID: mdl-29402316
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azepinas / Neoplasias Colorrectales / Proteínas Proto-Oncogénicas / Proteínas Serina-Treonina Quinasas / Proteínas de Ciclo Celular / Ensayos Antitumor por Modelo de Xenoinjerto Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Azepinas / Neoplasias Colorrectales / Proteínas Proto-Oncogénicas / Proteínas Serina-Treonina Quinasas / Proteínas de Ciclo Celular / Ensayos Antitumor por Modelo de Xenoinjerto Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos